PKPiotr Kubicki

Piotr Kubicki

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Piotr Kubicki has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A prolonged steroid therapy may be beneficial in some patients after the COVID-19 pneumonia

    by Sabina Kostorz-Nosal, Dariusz Jastrzębski, Michał Chyra, Piotr Kubicki, Michał Zieliński, Dariusz Ziora

    INTRODUCTION: This report introduces two cases presenting absorption of considerable radiological changes in the course of the coronavirus pneumonia in patients treated with prolonged oral steroids.CASES: The first case concerns a male receiving steroids only during hospitalisation in the Infectious Disease Hospital. After discharge, the patient experienced increasing dyspnoea resulting in hospitalisation in our Department of Lung Diseases. HRCT revealed progression of a bilateral, middle, and basal ground-glass opacity when compared to the examination performed at the early stage of the disease. The supplementary oxygen therapy and steroids were administered, followed by extended prednisone consumption up to 2 months after discharge. Follow-up HRCT revealed an almost complete absorption of the ground-glass opacity. The second case concerns a male treated with steroids only during hospitalisation in the Infectious Disease Hospital. Chest CT revealed widespread bilateral ground-glass opacities with consolidations. After discharge with no treatment, he suffered from severe dyspnoea and exercise intolerance, resulting in hospitalisation on the 7th day of home stay. Since then, a continued steroid treatment was administered resulting in a clinical, spirometric, and radiological improvement.CONCLUSIONS: Based on these observations, patients after the COVID-pneumonia may derive benefits from a prolonged steroid treatment. Therefore, this class of medications should be considered in SARS-CoV-2 patients, especially in patients with persistent radiological changes and dyspnoea requiring the supplementary oxygen therapy. However, randomised controlled trials are required to establish guidelines for the steroid treatment in this group of patients.


  • Open Access

    Hyponatraemia—Evaluation of Prevalence in Patients Hospitalized in the Pulmonary Department and Prognostic Significance in Lung Cancer Patients

    by Maja Zarzecka, Piotr Kubicki, Jerzy Kozielski

    Wstęp: Z doświadczeń klinicznych wynika, że danym o obniżonym stężeniu sodu we krwi przypisuje się niewielką rolę. Celem niniejszej pracy jest ocena częstości występowania hiponatremii u pacjentów pulmonologicznych oraz jej wpływu na rokowanie u chorych na raka płuca. Materiał i metody: Badanie miało charakter retrospektywny i dotyczyło chorych diagnozowanych i/lub leczonych w Klinice Chorób Płuc. Badana grupa liczyła 449 chorych. Wyodrębniono dwie grupy pacjentów: chorych z rozpoznanym rakiem płuca (n-290) oraz pacjentów z hiponatremią wolnych od tego rozpoznania (n-159). Obliczono częstość występowania hiponatremii poszczególnych stopni w obu grupach pacjentów, w tym w przypadkach raka z podziałem na typy i podtypy histologiczne. W opracowaniu uwzględniono występowanie chorób współistniejących oraz stosowaną terapię. Wyniki: Hiponatremię stwierdzono u 46.9% chorych na raka płuca, w tym hiponatremię łagodną (Na 135–130 mmol/l), umiarkowaną (Na 129–125 mmol/l ) i ciężką (Na < 125 mmol/l) odpowiednio u 66.9%, 25%, 8.1% pacjentów. W grupie 159 chorych bez raka hiponatremię łagodną stwierdzono u 81.8%, umiarkowaną u 13.2%, a ciężką u 5% chorych (głównie wśród pacjentów z rozpoznaniem chorób śródmiąższowych i obturacyjnych). Hiponatremię rozpoznano u 52.6% chorych z rakiem drobnokomórkowym, u 45.2% chorych z rakiem niedrobnokomórkowym. Nie stwierdzono statystycznie istotnych różnic w częstości występowania hiponatremii w poszczególnych podtypach raka niedrobnokomórkowego. W grupie chorych z rakiem stwierdzono znamiennie statystycznie większą częstość zgonów wewnątrzszpitalnych u pacjentów z hiponatremią tj. 28.7% vs. 7.8% (p < 0.001). Wnioski: Hiponatremia jest zaburzeniem stwierdzanym w różnych chorobach płuc, najczęściej bo u około 50% chorych z rozpoznanym rakiem płuca. Wystąpienie hiponatremii istotnie wpływa na gorsze rokowanie w tej grupie chorych.


  • Pulmonary Rehabilitation in Patients Referred for Lung Transplantation

    by D. Jastrzebski, M. Ochman, D. Ziora, L. Labus, K. Kowalski, J. Wyrwol, W. Lutogniewska, M. Maksymiak, B. Ksiazek, A. Magner, et al.

    Effectiveness of pulmonary rehabilitation in patients with chronic obstructive lung diseases, cystic fibrosis, and interstitial lung disease is well documented but little is known about the results of pulmonary rehabilitation in patients referred for lung transplantation. The purpose of this study is to prospectively examine the efficacy of Nordic walking, a low cost, accessible, and proven beneficial form of physical exercise, as a form of pulmonary rehabilitation in patients referred for lung transplantation. Twenty-two male patients referred for lung transplantation at the Department of Lung Diseases and Tuberculosis in Zabrze, Poland, were invited to take part in the study. The rehabilitation program, which was conducted for 12 weeks, was based on Nordic walking exercise training with ski poles. Lung function tests (FVC, FEV1), mobility (6 min walking test (6MWT)), rating of dyspnea (Oxygen Cost Index, MRC and Baseline Dyspnea Index), and quality of life assessments (SF-36) were performed before and after the completion of the exercise program. No adverse events were observed after completing the pulmonary rehabilitation program in patients referred for lung transplantation. After 12 weeks of pulmonary rehabilitation with Nordic walking we observed a significant increase in the mean distance walked in the 6MWT (310.2 m vs. 372.1 m, p < 0.05). The results of lung function tests also showed improvement in FVC. There were no significant differences in the perception of dyspnea before and after completing the rehabilitation program. General health and quality of life questionnaire (SF-36) showed improvement in the domain of social functioning (p < 0.05). In conclusion, pulmonary rehabilitation with a Nordic walking program is a safe and feasible physical activity in end-stage lung disease patients referred for lung transplantation and results in improvements in patients’ mobility and quality of life.


  • Open Access

    Dyspnea and quality of life in patients referred for lung transplantation

    by W. Lutogniewska, D. Jastrzebski, J. Wyrwol, B. Ksiazek, M. Ochman, K. Kowalski, A. Margas, P. Kubicki, J. Kozielski

    In the years 2007-2010 in the Department of Lung Diseases and Tuberculosis, Medical University of Silesia, 86 patients fulfilling ISHLT criteria qualified for lung transplantation. The aim of the study was to assess the correlation between dyspnea and quality of life, and how it is related to clinical data in the examined group. MRC, OCD, BDI and Borg scale were used for dyspnea evaluation, whereas quality of life was evaluated with SF-36 and SGRQ. A reference group consisted of 18 females and 68 males of the mean age 52 ± 10 years and BMI 24 ± 6. Thirty patients were diagnosed with IPF, 22 with COPD, and 34 with IIP. In the reference group, there was a significant correlation between dyspnea and quality of life: between MRC and Pf (SF-36 domain) r = -0.53; OCD and activity (SGRQ) r = 0.56; OCD and Pf r = -0.55; BDI and impact (SGRQ) r = 0.51; Borg scale and impact r = 0.47. In patients after lung transplantation, correlation between MRC and SF was r = -0.92; OCD and Pf, Bp, MH, PCS r = -0.97; OCD and RE r = -0.89; BDI and Pf r = -0.89; BDI and activity r = 0.9; BDI and PCS r = -0.84. Depending on the diagnosis, the strongest correlation in IIP patients was found between OCD and activity (r = 0.62), in COPD patients - between BDI and impact (r = 0.79), and in IPF patients r = - 0.62 for OCD and Pf. Summing up the results, we can state that there is a significant correlation between dyspnea and quality of life. This correlation seems the strongest in patients after lung transplantation. The correlation found between the level of dyspnea and quality of life domains in lung transplant patients suggests that it would be worthwhile to add questions regarding dyspnea to assess the severity of the disease, clinical symptoms, and functional impairment during referring the patients for lung transplantation.